The combined effect of serum cystatin C and dyslipidemia on hypertension in a large health check-up population in China

References

• Tam HP, Lin HJ, Weng SF, Hsu CC, Wang JJ, Su SB, Huang CC, Guo HR. The risk of stroke in physicians: a population-based cohort study in Taiwan. Epidemiol (Cambridge, Mass). 2017;28(Suppl 1):S48–s53. doi:10.1097/EDE.0000000000000720.
   PubMedGoogle Scholar
• Tsioufis KP, Kordalis A, Kasiakogias A, Dimitriadis K, Thomopoulos K, Kintis K, Flessas D, Liatakis I, Roussos D, Tousoulis D. Incidence of coronary artery disease and stroke in relation to the physical course of resistant hypertension: a time updated analysis of a 4 year cohort study. J Am Coll Cardiol. 2015;65(10, Supplement):A1461. doi:10.1016/j.jacc.2014.11.040.
   Web of Science ®Google Scholar
• Meissner A. Hypertension and the brain: a risk factor for more than heart disease. Cerebrovascular Dis (Basel, Switzerland). 2016;42(3–4):255–62. doi:10.1159/000446082.
   PubMed Web of Science ®Google Scholar
• Poulter NR, Prabhakaran D, Caulfield M. Hypertension. Lancet. 2015;386(9995):801–12. doi:10.1016/S0140-6736(14)61468-9.
   PubMed Web of Science ®Google Scholar
• Lee SH, Park SA, Ko SH, Yim HW, Ahn YB, Yoon KH, Cha BY, Son HY, Kwon HS. Insulin resistance and inflammation may have an additional role in the link between cystatin C and cardiovascular disease in type 2 diabetes mellitus patients. Metab Clin Exp. 2010;59(2):241–46. doi:10.1016/j.metabol.2009.07.019.
   PubMed Web of Science ®Google Scholar
• Peralta CA, Whooley MA, Ix JH, Shlipak MG. Kidney function and systolic blood pressure new insights from cystatin C: data from the heart and soul study. Am J Hypertens. 2006;19(9):939–46. doi:10.1016/j.amjhyper.2006.02.007.
   PubMed Web of Science ®Google Scholar
• Gurgus D, Ardeleanu E. Correlation between serum levels of cystatin C and essential hypertension in patients without chronic kidney disease. Arq Bras Cardiol. 2014;11(7):244–51.
   Google Scholar
• Shankar A, Teppala S. Relationship between serum cystatin C and hypertension among US adults without clinically recognized chronic kidney disease. J Am Soc of Hypertens. 2011;5(5):378–84. doi:10.1016/j.jash.2011.03.003.
   PubMed Web of Science ®Google Scholar
• Jotoku M, Okura T, Enomoto D, Irita J, Miyoshi K, Kurata M, Fukuoka T, Higaki J. Association between serum cystatin C and inflammatory cytokines in patients with essential hypertension. J Hypertens. 2008;16(3):345–52.
   Google Scholar
• Esteve E, Ricart W, Fernandez-Real JM. Hypercholesterolemia and inflammation: an evolutionary conserved mechanism. Clin Nutr. 2005;24(1):16–31. doi:10.1016/j.clnu.2004.08.004.
   PubMed Web of Science ®Google Scholar
• Waheed P, Naveed AK, Farooq F. Levels of inflammatory markers and their correlation with hypercholesterolemia in diabetics. J Coll Phys and Surg– Pak: JCPSP. 2009;19(4):207–10.
   PubMed Web of Science ®Google Scholar
• Borghi C, Rodriguez-Artalejo F, De Backer G, Dallongeville J, Medina J, Guallar E, Perk J, Banegas JR, Tubach F, Roy C, et al. The association between blood pressure and lipid levels in Europe: European study on cardiovascular risk prevention and management in usual daily practice. J Hypertens. 2016;34(11):2155–63. doi:10.1097/HJH.0000000000001078.
   PubMed Web of Science ®Google Scholar
• Bonaa KH, Thelle DS. Association between blood pressure and serum lipids in a population. The Tromso Study Circ. 1991;83(4):1305–14. doi:10.1161/01.CIR.83.4.1305.
   Google Scholar
• Cicero AF, D’Addato S, Veronesi M, Rosticci M, Santi F, Dormi A, Borghi C. Relationship between blood pressure, cholesterolemia and serum apolipoprotein B in a large population sample: the Brisighella heart study. J Hypertens. 2012;30(3):492–96. doi:10.1097/HJH.0b013e32834f6b11.
   PubMed Web of Science ®Google Scholar
• James JE. Hypertension control and cardiovascular disease. Lancet (London, England). 2017;389(10065):154. doi:10.1016/S0140-6736(17)30018-1.
   PubMedGoogle Scholar
• Ahn E, D W S, H K Y, Yun JM, Chun SH, Suh B, Lee H, Son KY, Cho B. Treatment gap in the national health-screening program in Korea: claim-based follow-up of statin use for sustained hypercholesterolemia[J]. J Korean Med Sci. 2015;30(9):1266–72. doi:10.3346/jkms.2015.30.9.1266.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang L, Wang F, Liu L, Wang H. Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey[J]. Am J Hypertens. 2014;27(11):1355–61. doi:10.1093/ajh/hpu053.
   PubMed Web of Science ®Google Scholar
• Dandana A, Gammoudi I, Chalghoum A, Chahed H, Addad F, Ferchichi S, Miled A. Clinical utility of serum cystatin C in predicting coronary artery disease in patients without chronic kidney disease. J Clin Lab Anal. 2014; 28(3):191–7. doi:10.1002/jcla.21665. Epub 2014 Jan 29.
   Google Scholar
• Sahakyan K, Klein BE, Lee KE, Tsai MY, Klein R. Serum cystatin C and the incidence of hypertension in type 1 diabetes mellitus. Am J Hypertens. 2011;24(1):59–63. doi:10.1038/ajh.2010.215.
   PubMed Web of Science ®Google Scholar
• Wang Y, Su X, Zhang W, Yang W, Wang Y, He Y. Correlation between serum cystatin C level and elderly hypertensive patients combined coronary heart disease. Int J Clin Exp Med. 2015;8(4):6287–90.
   PubMed Web of Science ®Google Scholar
• Yang S, Song L, Zhao L, Dong P, Lai L, Wang H. Predictive value of cystatin C in people with suspected or established coronary artery disease: a meta-analysis. Atherosclerosis. 2017;263:60–67. doi:10.1016/j.atherosclerosis.2017.05.025.
   PubMed Web of Science ®Google Scholar
• Arpegard J, Ostergren J, de Faire U, Hansson LO, Svensson P. Cystatin C–a marker of peripheral atherosclerotic disease? Atherosclerosis. 2008;199(2):397–401. doi:10.1016/j.atherosclerosis.2007.11.025.
   PubMed Web of Science ®Google Scholar
• Shlipak MG, Katz R, Cushman M, Sarnak MJ, Stehman-Breen C, Psaty BM, Siscovick D, Tracy RP, Newman A, Fried L. Cystatin-C and inflammatory markers in the ambulatory elderly. Am J Med. 2005;118(12):1416. doi:10.1016/j.amjmed.2004.04.032.
   PubMedGoogle Scholar
• Nordestgaard BG, Freiberg JJ, Jensen JS, Tybjaerg-Hansen A. Non-fasting triglycerides and risk of ischemic stroke in the general population. Atherosclerosis Suppl. 2008;9(1):15. doi:10.1016/S1567-5688(08)70057-6.
   PubMed Web of Science ®Google Scholar
• Okamura T, Tanaka H, Miyamatsu N, Hayakawa T, Kadowaki T, Kita Y, Nakamura Y, Okayama A, Ueshima H. The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort. Atherosclerosis. 2007;190(1):216–23. doi:10.1016/j.atherosclerosis.2006.01.024.
   PubMed Web of Science ®Google Scholar
• Otsuka T, Takada H, Nishiyama Y, Kodani E, Saiki Y, Kato K, Kawada T. Hypercholesterolemia and the risk of developing hypertension in a working‐age male population. J Am Heart Assoc:Cardiovasc Cerebrovascular Dis. 2016;5(3):e003053. doi:10.1161/JAHA.115.003053.
   PubMed Web of Science ®Google Scholar
• Yao Y, He L, Jin Y, Chen Y, Tang H, Song X, Ding L, Qi Q, Huang ZWang Q et al. The relationship between serum calcium level, blood lipids, and blood pressure in hypertensive and normotensive subjects who come from a normal university in east of China. Biol Trace Elem Res. 2013; 153(1–3):35–40. doi:10.1007/s12011-013-9646-3.
   PubMed Web of Science ®Google Scholar
• Guo ZR, Hu XS, Wu M, Zhou MH, Zhou ZY. A prospective study on the association between hypercholesterolemia and hypertension. Zhonghua Liu Xing Bing Xue Za Zhi. 2009;30(6):554–58.
   PubMedGoogle Scholar
• de Lombera Romero F, Fernandez Casares S, Gascuena Rubia R, Lazaro M, Hernandez Simon P, Saavedra Falero J, Sanchez Sanchez V, Velazquez Martin MT, Garcia Pascual J, Saenz de la Calzada C. Hypertension and hypercholesterolemia. Rev Esp Cardiol. 1998;51(Suppl 4):24–35.
   PubMedGoogle Scholar
• Ferrario CM. Importance of the renin-angiotensin-aldosterone system (RAS) in the physiology and pathology of hypertension. An Overview Drugs. 1990;39(Suppl 2):1–8.
   Google Scholar
• Okura T, Jotoku M, Irita J, Enomoto D, Nagao T, Desilva VR, Yamane S, Pei Z, Kojima S, Hamano Y, et al. Association between cystatin C and inflammation in patients with essential hypertension. Clin Exp Nephrol. 2010;14(6):584–88. doi:10.1007/s10157-010-0334-8.
   PubMed Web of Science ®Google Scholar
• Shu Y, He S, Chen XP, Lu ZB, Yang R, Liu K, Cui KJ, Huang DJ. Relations between fasting serum lipids and high-sensitivity C-reactive protein level in Chengdu residents. Zhonghua Xin Xue Guan Bing Za Zhi. 2012;40(2):125–30.
   PubMedGoogle Scholar